{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:09:54Z","timestamp":1783512594084,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Contemporary influenza A H3N2 viruses circulating since 2016 have acquired a glycosylation site in the neuraminidase in close proximity to the enzymatic active site. Here, we investigate if this S245N glycosylation site, as a result of antigenic evolution, can impact binding and function of human monoclonal antibodies that target the conserved active site. While we find that a reduction in the inhibitory ability of neuraminidase active site binders is measurable, this class of broadly reactive monoclonal\u00a0antibodies maintains protective efficacy in vivo.<\/jats:p>","DOI":"10.1038\/s41467-022-35586-7","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T17:05:09Z","timestamp":1671642309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-7650","authenticated-orcid":false,"given":"Daniel","family":"Stadlbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7450-6624","authenticated-orcid":false,"given":"Meagan","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-3740","authenticated-orcid":false,"given":"Xueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6374-0343","authenticated-orcid":false,"given":"Hongquan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Strohmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Luksza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-6916","authenticated-orcid":false,"given":"Harm","family":"van Bakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-5096","authenticated-orcid":false,"given":"Viviana","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6129-2532","authenticated-orcid":false,"given":"Ali H.","family":"Ellebedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2419","authenticated-orcid":false,"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"35586_CR1","unstructured":"WHO. (World Health Organisation, 2018) https:\/\/www.who.int\/news\/item\/13-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year."},{"key":"35586_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2105\/AJPH.2019.305557","volume":"110","author":"B Jester","year":"2020","unstructured":"Jester, B., Uyeki, T. & Jernigan, D. Fifty years of influenza A(H3N2) following the pandemic of 1968. Am. J. Public Health 110, 669\u2013676 (2020).","journal-title":"Am. J. Public Health"},{"key":"35586_CR3","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"S Zost","year":"2017","unstructured":"Zost, S. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578\u201312583 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35586_CR4","doi-asserted-by":"publisher","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","volume":"13","author":"NC Wu","year":"2017","unstructured":"Wu, N.C. et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 13, e1006682 (2017).","journal-title":"PLoS Pathog."},{"key":"35586_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39276-1","volume":"9","author":"PA Jorquera","year":"2019","unstructured":"Jorquera, P. A. et al. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011\u20132018. Sci. Rep. 9, 1\u201316 (2019).","journal-title":"Sci. Rep."},{"key":"35586_CR6","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1038\/s41564-019-0522-6","volume":"4","author":"H Wan","year":"2019","unstructured":"Wan, H. et al. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A\/Hong Kong\/4801\/2014 vaccine strain. Nat. Microbiol. 4, 2216\u20132225 (2019).","journal-title":"Nat. Microbiol."},{"key":"35586_CR7","doi-asserted-by":"publisher","first-page":"e1008411","DOI":"10.1371\/journal.ppat.1008411","volume":"16","author":"H Powell","year":"2020","unstructured":"Powell, H. & Pekosz A. Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding. PLoS Pathog. 16, e1008411 (2020).","journal-title":"PLoS Pathog"},{"key":"35586_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","volume":"218","author":"E Erbelding","year":"2018","unstructured":"Erbelding, E. et al. A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases. J. Infect. Dis. 218, 347\u2013354 (2018).","journal-title":"J. Infect. Dis."},{"key":"35586_CR9","doi-asserted-by":"publisher","first-page":"e02332","DOI":"10.1128\/mBio.02332-17","volume":"9","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9, e02332\u201302317 (2018).","journal-title":"mBio"},{"key":"35586_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/science.aay0678","volume":"366","author":"D Stadlbauer","year":"2019","unstructured":"Stadlbauer, D. et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366, 499\u2013504 (2019).","journal-title":"Science"},{"key":"35586_CR11","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1021\/pr400329k","volume":"12","author":"Y An","year":"2013","unstructured":"An, Y. et al. Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms. J. Proteome Res. 12, 3707\u20133720 (2013).","journal-title":"J. Proteome Res."},{"key":"35586_CR12","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35586_CR13","doi-asserted-by":"publisher","DOI":"10.3791\/51112","author":"I Margine","year":"2013","unstructured":"Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. 81, e51112\u00a0(2013).","journal-title":"J. Vis. Exp."},{"key":"35586_CR14","doi-asserted-by":"publisher","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","volume":"22","author":"Y Shu","year":"2017","unstructured":"Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 22, 30494 (2017).","journal-title":"Euro Surveill"},{"key":"35586_CR15","doi-asserted-by":"crossref","unstructured":"Webb, B. & Sali, A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics 54, 5.6.1\u20135.6.37 (2016).","DOI":"10.1002\/cpbi.3"},{"key":"35586_CR16","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.1128\/JVI.01426-12","volume":"86","author":"X Zhu","year":"2012","unstructured":"Zhu, X. et al. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J. Virol. 86, 13371\u201313383 (2012).","journal-title":"J. Virol."},{"key":"35586_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"35586_CR18","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","volume":"82","author":"X Xu","year":"2008","unstructured":"Xu, X., Zhu, X., Dwek, R., Stevens, J. & Wilson, I. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J. Virol. 82, 10493\u201310501 (2008).","journal-title":"J. Virol."},{"key":"35586_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0304-3991(99)00043-1","volume":"77","author":"C Potter","year":"1999","unstructured":"Potter, C. et al. Leginon: a system for fully automated acquisition of 1000 electron micrographs a day. Ultramicroscopy 77, 153\u2013161 (1999).","journal-title":"Ultramicroscopy"},{"key":"35586_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jsb.2009.01.002","volume":"166","author":"G Lander","year":"2009","unstructured":"Lander, G. et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 166, 95\u2013102 (2009).","journal-title":"J. Struct. Biol."},{"key":"35586_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jsb.2009.01.004","volume":"166","author":"N Voss","year":"2009","unstructured":"Voss, N., Yoshioka, C., Radermacher, M., Potter, C. & Carragher, B. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J. Struct. Biol. 166, 205\u2013213 (2009).","journal-title":"J. Struct. Biol."},{"key":"35586_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"S Scheres","year":"2012","unstructured":"Scheres, S. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"35586_CR23","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"E Pettersen","year":"2004","unstructured":"Pettersen, E. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35586-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35586-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35586-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T17:19:37Z","timestamp":1671643177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35586-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35586"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35586-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"26 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Washington University has filed a patent application for antibodies 1G01, 1E01, and 1G04 with A.H.E., F.K., and I.A.W. named as inventors\u00a0and\u00a0A.H.E., F.K., and I.A.W.\u00a0have received royalties from licensing 1G01 for clinical development. F.K. is currently consulting for Avimex, GSK, Third Rock Ventures, and Pfizer and is receiving research support from Dynavax. Research support was provided in the past by GSK and Pfizer to the Krammer laboratory. The Ellebedy laboratory received funding from Emergent BioSolutions, Moderna, and AbbVie in the form of scientific research agreements that are unrelated to the data presented in the current study.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7864"}}